Celofem 2.5 mg Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Celofem 2.5 mg Tablet contains letrozole, a non-steroidal aromatase inhibitor. Its labelling describes it for the treatment of breast cancer in women who have gone through menopause, as adjuvant therapy to reduce the risk of recurrence after early-stage breast cancer surgery, as neoadjuvant therapy to shrink breast tumours before surgery, and occasionally for ovarian function suppression during fertility treatment, especially in women with polycystic ovary syndrome (PCOS). It is described as blocking the aromatase enzyme and stopping estrogen production, which is responsible for the growth of cancer cells.
Product Information
The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of breast cancer in postmenopausal women
- Described as adjuvant therapy to reduce the risk of recurrence after early-stage breast cancer surgery, and as neoadjuvant therapy to shrink breast tumours before surgery
- Described as occasionally used for ovarian function suppression during fertility treatment, especially in women with PCOS
- Described as blocking the aromatase enzyme and stopping estrogen production that drives cancer-cell growth
Described Dosage & Administration
- Taken with or without food, swallowed whole with water; the tablet should not be crushed, broken, or chewed
- Taken at the same time each day for best results
- It should not be stopped even if the patient feels better
Described Side Effects
Commonly described side effects include:
- Tiredness and weakness
- Increased sweating
- Feeling unwell
- Pain in the joints
- Hot flushes (feeling of warmth)
These are described as commonly temporary. The doctor should be consulted if they persist.
Precautions
- Not for pregnant or breastfeeding women, and not for children
- Driving should be avoided after taking the medicine
- A complete medical history should be shared with the doctor or healthcare team
- It should not be stopped even if the patient feels better
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains letrozole and is used for the treatment of breast cancer in postmenopausal women, as adjuvant or neoadjuvant therapy, and occasionally for ovarian function suppression in fertility treatment. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as swallowed whole with water, with or without food, at the same time each day, without crushing, breaking, or chewing, and not stopped early.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.